Keywords: azd3480, go, into, ph, iii, cds, testing

AZD3480 will not go into Ph III CDS testing

Article | 15 December 2008

Print This

Anglo-Swedish drug major AstraZeneca and US drug developer Targacept say that top-line results from a Phase IIb trial of AZD3480 ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in